Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
about
Proteomics in cardiovascular disease: recent progress and clinical implication and implementation.Mass spectrometry protein tests: ready for prime time (or not).The long path towards implementation of clinical proteomics: Exemplified based on CKD273.Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease.
P2860
Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Implementation of CE-MS-identi ...... opment and patient management.
@en
type
label
Implementation of CE-MS-identi ...... opment and patient management.
@en
prefLabel
Implementation of CE-MS-identi ...... opment and patient management.
@en
P2860
P356
P1433
P1476
Implementation of CE-MS-identi ...... opment and patient management.
@en
P2093
Anna Stepczynska
P2860
P304
P356
10.4155/BIO.16.8
P577
2016-02-19T00:00:00Z